Rodolphe Besserve
Director/Board Member bei THERANEXUS
Profil
Rodolphe Besserve is the founder of eureKARE SA (2020) and eureKING SA. He is currently the Chairman of Muiscare SAS, an Independent Director at Theranexus SA, and a Director at Stellate Therapeutics SAS, Omne Possibile, Meletios Therapeutics SAS, and eureKASYNBIO SRL.
His former position was as Head-ECM Division at Société Générale SA. He received his undergraduate degree from École Supérieure de Chimie Physique Électronique and his graduate degree from IAE Lyon School of Management.
Aktive Positionen von Rodolphe Besserve
Unternehmen | Position | Beginn |
---|---|---|
THERANEXUS | Director/Board Member | - |
Meletios Therapeutics SAS
Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Director/Board Member | - |
eureKING SA
eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France. | Founder | - |
Muiscare SAS | Chairman | - |
Omne Possibile | Director/Board Member | - |
Stellate Therapeutics SAS
Stellate Therapeutics SAS BiotechnologyHealth Technology Stellate Therapeutics, Inc. provides micro biome medicine. It also offers therapeutic products and associated diagnosis tools. The company was founded by Antoine Danchin and is headquartered in Paris, France. | Director/Board Member | - |
eureKASYNBIO SRL | Director/Board Member | - |
Ehemalige bekannte Positionen von Rodolphe Besserve
Unternehmen | Position | Ende |
---|---|---|
SOCIÉTÉ GÉNÉRALE | Corporate Officer/Principal | - |
eureKARE SA
eureKARE SA BiotechnologyHealth Technology eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation. | Chief Executive Officer | - |
Ausbildung von Rodolphe Besserve
École Supérieure de Chimie Physique Électronique | Undergraduate Degree |
IAE Lyon School of Management | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SOCIÉTÉ GÉNÉRALE | Finance |
THERANEXUS | Health Technology |
Private Unternehmen | 7 |
---|---|
Stellate Therapeutics SAS
Stellate Therapeutics SAS BiotechnologyHealth Technology Stellate Therapeutics, Inc. provides micro biome medicine. It also offers therapeutic products and associated diagnosis tools. The company was founded by Antoine Danchin and is headquartered in Paris, France. | Health Technology |
Omne Possibile | |
eureKARE SA
eureKARE SA BiotechnologyHealth Technology eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation. | Health Technology |
Meletios Therapeutics SAS
Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Health Technology |
eureKING SA
eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France. | Finance |
Muiscare SAS | |
eureKASYNBIO SRL |